Segment Reporting (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||
| Net Revenue | $ 9,277 | $ 8,133 | $ 17,675 | $ 15,383 |
| Advertising and marketing | 217 | 213 | 370 | 365 |
| Depreciation and amortization | 309 | 281 | 608 | 556 |
| Provision for litigation | 82 | 96 | 82 | 247 |
| Investment income | (88) | (70) | (169) | (158) |
| Interest expense | 218 | 195 | 403 | 377 |
| Other (income) expense, net | (31) | (16) | (106) | (21) |
| Income tax expense | 1,098 | 971 | 2,028 | 1,722 |
| Net Income | 4,388 | 3,701 | 8,270 | 6,981 |
| Payment Solutions | ||||
| Segment Reporting [Line Items] | ||||
| Net Revenue | 9,277 | 8,133 | 17,675 | 15,383 |
| Personnel | 1,947 | 1,852 | 3,984 | 3,540 |
| Professional fees | 128 | 107 | 252 | 220 |
| Data processing and telecommunications | 369 | 314 | 718 | 606 |
| Gain (loss) for contracts to purchase and sell foreign currency | 59 | 41 | 117 | 42 |
| Advertising and marketing | 217 | 213 | 370 | 365 |
| Depreciation and amortization | 309 | 281 | 608 | 556 |
| Provision for litigation | 82 | 96 | 82 | 247 |
| Investment income | (88) | (70) | (169) | (158) |
| (Gains) losses on equity investments, net | 2 | (4) | 68 | 25 |
| Interest expense | 218 | 195 | 403 | 377 |
| Other (income) expense, net | (31) | (16) | (106) | (21) |
| Income tax expense | 1,098 | 971 | 2,028 | 1,722 |
| Other segment items | 579 | 452 | 1,050 | 881 |
| Net Income | $ 4,388 | $ 3,701 | $ 8,270 | $ 6,981 |
| X | ||||||||||
- Definition Equity Securities, FV-NI And Without Readily Determinable Fair Value, Gain (Loss) No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expenses incurred in the period for information technology and data processing products and services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|